A clinical trial of amygdalin (Laetrile) in the treatment of human cancer

The New England Journal of Medicine
C G MoertelJ P Davignon

Abstract

One hundred seventy-eight patients with cancer were treated with amygdalin (Laetrile) plus a "metabolic therapy" program consisting of diet, enzymes, and vitamins. The great majority of these patients were in good general condition before treatment. None was totally disabled or in preterminal condition. One third had not received any previous chemotherapy. The pharmaceutical preparations of amygdalin, the dosage, and the schedule were representative of past and present Laetrile practice. No substantive benefit was observed in terms of cure, improvement or stabilization of cancer, improvement of symptoms related to cancer, or extension of life span. The hazards of amygdalin therapy were evidenced in several patients by symptoms of cyanide toxicity or by blood cyanide levels approaching the lethal range. Patients exposed to this agent should be instructed about the danger of cyanide poisoning, and their blood cyanide levels should be carefully monitored. Amygdalin (Laetrile) is a toxic drug that is not effective as a cancer treatment.

References

Mar 1, 1978·Journal of Pharmaceutical Sciences·J JeeP Lim

❮ Previous
Next ❯

Citations

Mar 20, 2003·Archives of Pharmacal Research·Hee-Young KwonJeong Hee Kim
Oct 21, 2009·Der Urologe. Ausg. A·T SchnöllerL Rinnab
Nov 16, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Stefania MilazzoEdzard Ernst
Oct 23, 1997·Journal of the American Dietetic Association·N Spaulding-Albright
Jan 11, 2000·Emergency Medicine Clinics of North America·L Nelson, J Perrone
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E Ernst, B R Cassileth
Mar 22, 2002·The Lancet Oncology·A J Vickers, B R Cassileth
Jan 28, 1982·The New England Journal of Medicine·A S Relman
Jun 17, 1982·The New England Journal of Medicine·B R Cassileth
Jul 8, 1982·The New England Journal of Medicine
Oct 27, 1983·The New England Journal of Medicine·F T Fitzgerald
Jun 20, 1985·The New England Journal of Medicine·M Markman
Apr 25, 1991·The New England Journal of Medicine·B R CassilethD J Schultz
Jan 1, 1984·Nutrition and Cancer·V Herbert
Dec 10, 2002·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Jeffrey D White
Sep 22, 2005·European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine·Brian O'BrienTim Leong
Apr 1, 1990·Journal of Clinical Pharmacy and Therapeutics·M V NelsonH Areny
Aug 2, 2008·Biological & Pharmaceutical Bulletin·Hye-Jeong HwangDae-Hyun Hahm
Sep 1, 2007·Journal of the Society for Integrative Oncology·Andrew J Vickers
Jan 14, 2011·Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan·Keizo Umegaki
May 9, 2013·Future Medicinal Chemistry·Juan J Perez
Sep 19, 2014·Nature Reviews. Cancer·David H Gorski
Sep 11, 2014·Journal of Cancer Research and Therapeutics·Zuoqing Song, Xiaohong Xu
May 23, 2012·Journal of Dietary Supplements·John B Bossaer, Brian L Odle
Jan 9, 2014·Immunopharmacology and Immunotoxicology·Shailendra Kapoor
Jan 1, 1984·Journal of Toxicology. Clinical Toxicology·M D HolzbecherH A Ellenberger
Jan 1, 1996·Cancer Investigation·B R Cassileth, C C Chapman
Jan 1, 1986·Cancer Investigation·B R Cassileth
Feb 2, 2016·Life Sciences·Jasmina MakarevićRoman A Blaheta
Mar 24, 2016·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Roman A BlahetaEva Juengel
Aug 2, 2011·The American Journal of the Medical Sciences·Franklin G Miller
Apr 1, 1986·Gastrointestinal Endoscopy·P Froelicher, G Miller
Jul 22, 2008·Hematology/oncology Clinics of North America·Mary L Hardy
Feb 21, 2006·Anesthesiology Clinics·Jacqueline Filshie, Carolyn N J Rubens
Apr 4, 2006·Hematology/oncology Clinics of North America·Lawrence B Berk
Feb 1, 1983·Disease-a-month : DM·J O Woolliscroft
Aug 1, 1995·Controlled Clinical Trials·M H Gail
Feb 1, 1986·Seminars in Oncology Nursing·V Herbert, C H Yarbro
Aug 23, 2005·Journal of the American Academy of Dermatology·Nathaniel Jellinek, Mary E Maloney
May 9, 2003·The Urologic Clinics of North America·Barrie R Cassileth, Andrew J Vickers
Jan 1, 1995·Clinical Oncology : a Journal of the Royal College of Radiologists·E Ernst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.